07:00 , Jun 18, 2012 |  BioCentury  |  Emerging Company Profile

Armour: Relaxin in CRPC

Armour Therapeutics Inc. 's relaxin receptor antagonists may provide a complementary hormonal therapy that can be given either with or after anti-androgen therapy in prostate cancer patients. Targeting a secondary pathway alongside an androgen pathway...